¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"renal region"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® inguinal region of abdomen ÇÑ±Û »ô, ¼­ÇýºÎ, »ô°í¶û
¼³¸í   
  ¸öÅë¿¡¼­ ´Ù¸®·Î °¥¶óÁ® ³ª¿Â ºÎÀ§. º¸Å렻矱¸´Ï¶ó°í ºÎ¸¥´Ù.
¿µ¹® renal biopsy ÇÑ±Û ÄáÆÏ»ý°Ë
¼³¸í   
  ÄáÆÏÀÇ º´º¯ÀÌ Àǽɵɠ¶§ È®ÁøÀ» À§ÇØ ÁÖ»ç¹Ù´Ã µîÀ» ÀÌ¿ëÇÏ¿© ÄáÆÏÁ¶Á÷À» ÀϺΠ¶¼¾î³»¼­ Çö¹Ì°æÀ¸·Î °Ë°æÇϴ °Í.
¿µ¹® renal hypertension ÇÑ±Û ÄáÆÏ¼º°íÇ÷¾Ð
¼³¸í   
  ÄáÆÏ½ÇÁúÀÇ º´º¯À¸·Î ÀÎÇØ ¾ß±âµÈ °íÇ÷¾Ð. ÄáÆÏÀÇ ´ëÇ¥Àû ±â´ÉÀº ³ëÆó¹° ¹× ¼öºÐÀÇ ¹è¼³ÀÌ´Ù. ±×·±µ¥ ÀÌ·¯ÇÑ ÄáÆÏ±â´É¿¡ ÀÌ»óÀÌ »ý°åÀ» °æ¿ì Ã¼³»¿¡ °úÀ×¼öºÐÀÇ ÃàÀûÀÌ ¹ß»ýÇϰԠµÈ´Ù. À̿Ͱ°Àº °úÀ×¼öºÐÀÇ ÃàÀûÀº Ç÷°ü³» Á¤¼ö¾ÐÀ» »ó½Â½ÃÄÑ °íÇ÷¾ÐÀ» À¯¹ßÇϰԠµÈ´Ù. Ä¡·á´Â ¿øÀΠÄáÆÏº´ÀÇ ±³Á¤À̸ç ÀÌÀ¯¸¦ ¸ð¸£´Â ¿ø¹ß°íÇ÷¾Ð°ú ´Þ¸® ÄáÆÏ¼º°íÇ÷¾ÐÀÇ °æ¿ì¿¡´Â ¿øÀΠÄáÆÏº´ÀÌ ±³Á¤µÇ¸é °íÇ÷¾Ðµµ »ç¶óÁö°Ô µÈ´Ù.
¿µ¹® renal cell carcinoma ÇÑ±Û ÄáÆÏ¼¼Æ÷¾ÏÁ¾
¼³¸í   
  ÄáÆÏ¿¡ »ý±ä ¿ø½ÃÄáÆÏÁ¶Á÷¿¡¼­ ¹ß»ýÇÑ ¾Ï. ÁַΠ¿ø½Ã¼¼´¢°üÁ¶Á÷¿¡¼­ ¹ß»ýÇÑ´Ù. ´ëÇ¥ÀûÀΠ¼¼Æ÷Á¶Á÷ÇüÀº ¿°»ö½Ã ¼¼Æ÷ÁúÀÌ ¸¼°Ô ºñ¾îº¸À̴ ¸¼Àº¼¼Æ÷¾ÏÁ¾ÀÌ´Ù. Ä¡·á´Â ¼ö¼ú°ú Ç×¾ÏÈ­Çпä¹ýÀ̸砾ÆÁÖ µå¹°Áö¸¸ ÀúÀý·Î ³´´Â °æ¿ìµµ Àִ °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù.
¿µ¹® renal transplantation ÇÑ±Û ÄáÆÏÀ̽Ä
¼³¸í   
  ÄáÆÏº´À» °¡Áö°í ÀÖÀ¸³ª Ä¡·á°¡ ºÒ°¡´ÉÇÑ ¸¸¼ºÄáÆÏ±â´É»ó½Ç µîÀÇ Áúº´À» °¡Áø È¯ÀÚÀÇ ½ÅÀåÀ» ¶¼¾î³»°í È¯ÀÚ¿Í Ç׿ø¼ºÀÌ À¯»çÇÑ »ç¶÷ÀÇ ÄáÆÏÀ» À̽ÄÇØÁִ °Í. ÀÌ ¶§ ¼­·Î°£ÀÇ Ç׿ø¼ºÀÇ À¯»çÁ¡ÀÌ ¸¹¾Æ¾ß °ÅºÎ¹ÝÀÀÀÌ ÀϾÁö ¾Ê´Â´Ù. ±×¸®°í ÀÏ´Ü ÄáÆÏÀ̽ÄÀ» ¹ÞÀº »ç¶÷Àº ¿À·£±â°£ µ¿¾È ¸é¿ª¾ïÁ¦Á¦¸¦ Åõ¿©ÇÏ¿© °ÅºÎ¹ÝÀÀÀ» ÁÙ¿©¾ß ÇÑ´Ù. ´ë°³ À̽ĵȠÄáÆÏÀº ¾ûµ¢»À¿À¸ñ¿¡ À§Ä¡ÇϰԠµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • auditory perceptive region
    û°¢Áö°¢Áö¿ª, °¡Ã»¿µ¿ª
  • ampullary region
    ÆØ´ëºÎÀ§
  • complementarity determining region
    »óº¸°áÁ¤ºÎÀ§
  • condylar region
    °üÀýÀ¶±âºÎÀ§
  • conserved region
    º¸Á¸ºÎÀ§
  • constant region
    ºÒº¯ºÎÀ§
  • critical region
    1. °áÁ¤ÀûºÎÀ§ 2. ±â°¢¿ª
  • deltoid region
    ¾î±ú¼¼¸ð±ÙºÎÀ§, »ï°¢±ÙºÎÀ§
  • epigastric region
    ¸íÄ¡ºÎÀ§
  • frontal region
    À̸¶ºÎÀ§, ÀüµÎºÎ
  • gluteal region
    º¼±âºÎÀ§, º¼±â, µÐºÎ
  • hypervariable region
    °íº¯À̺ÎÀ§
  • hypochondriac region
    °¥ºñ¹ØºÎÀ§, ´ÁÇϺÎ
  • hinge region
    °æÃ¸ºÎÀ§, µ¹Â¼±âºÎÀ§
  • infratemporal region
    °üÀھƷ¡ºÎÀ§, ÃøµÎÇϺÎ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • region
    ºÎÀ§, ºÎ
  • abdominal region
    ¹èºÎÀ§, º¹ºÎ
  • ampullary region
    ÆØ´ëºÎ
  • buccal region
    º¼ºÎÀ§
  • gluteal region
    º¼±âºÎÀ§, º¼±â
  • infratemporal region
    °üÀھƷ¡ºÎÀ§, ÃøµÎÇϺÎ
  • inguinal region
    »ô±¼ºÎÀ§
  • orbital region
    ´«ºÎÀ§
  • parietal region
    ¸¶·çºÎÀ§
  • parotid region
    ±Í¹Ø»ùºÎÀ§
  • pectoral region
    Å«°¡½¿±ÙºÎÀ§
  • pubic region
    µÎµ¢ºÎÀ§
  • sacral region
    ¾ûÄ¡ºÎÀ§, õ°ñºÎ
  • temporal region
    °üÀÚºÎÀ§, ÃøµÎºÎ
  • umbilical region
    ¹è²ÅºÎÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • abdominal region
    ¹èºÎÀ§, º¹ºÎ
  • auditory perceptive region
    û°¢Áö°¢Áö¿ª, °¡Ã»¿µ¿ª
  • axillary region
    °Üµå¶ûºÎÀ§
  • buccal region
    º¼ºÎÀ§
  • cervical region
    ¸ñºÎÀ§
  • complementarity determining region
    »óº¸¼º°áÁ¤ºÎÀ§
  • condylar region
    °üÀýÀ¶±âºÎÀ§
  • conserved region
    º¸Á¸À¯ÀüÀÚ
  • constant region
    ºÒº¯ºÎÀ§
  • critical region
    °áÁ¤ÀûºÎÀ§, ±â°¢¿ª
  • deltoid region
    ¾î±ú¼¼¸ð±ÙºÎÀ§
  • epigastric region
    ¸íÄ¡ºÎÀ§
  • frontal region
    À̸¶ºÎÀ§
  • gluteal region
    º¼±âºÎÀ§, º¼±â
  • hinge region
    °æÃ¸ºÎÀ§, µ¹Â¼±âºÎÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • D region
    D¿µ¿ª (H-2Á¶Á÷Ç׿øÀÇ)
  • I region-associated antigen
    Ir¿¬°üÇ׿ø
  • ROI(region of interest)
    °ü½É ¿µ¿ª
  • ROI, see region of interest
    °ü½É¿µ¿ª
  • abdominal region
    º¹ºÎ(º¹ºÎ).
  • anterior hypothalamic region
    ½Ã»óÇϺξձ¸¿ª
  • arctic region
    ºÏ±Ø±¸(ËÓ˻˴).
  • foveal region of retina
    ¸Á¸·Á߽ɿÍ(ØÑدñéãýèÀ).
  • foveal region of retina
    ¸Á¸·Á߽ɿÍ(ØÑدñéãýèÀ), ¸Á¸·Á߽ɿÀ¸ñ
  • framework region
    ±âº»Æ²ºÎÀ§
  • framework region in immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°°ñ°ÝºÎ
  • glottic region
    ¼º¹®¿ª
  • gluteal region
    º¼±â
  • gluteal region<³ª> regio glutea
    µÐºÎ.
  • gluteal region<³ª> regio glutea
    µÐ ºÎ(ÔëÝ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • renal region
    ½ÅÀåºÎÀ§, ½ÅºÎ(ãìÝ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • abdominal region
    º¹ºÎ(º¹ºÎ).
  • anterior hypothalamic region
    ½Ã»óÇϺξձ¸¿ª
  • antigen, I region-associated
    Ir¿¬°üÇ׿ø
  • arctic region
    ºÏ±Ø±¸(ËÓ˻˴).
  • arytenoid region
    ÇÇ¿­ºÎ ÈĵÎÀÇ
  • auditory perceptive region
    °¡Ã»Áö¿ª(ʦôéò¢æ´).
  • auditory perceptive region
    °¡Ã»Áö¿ª
  • axillary region
    °Üµå¶ûºÎÀ§
  • buccal region
    º¼ºÎÀ§
  • buccal region =regio buccalis <³ª>
    ÇùºÎ
  • calcaneal region<³ª> regio calcanea
    Á¾ºÎ.
  • cervical region
    ¸ñºÎÀ§
  • complementarity determining region (CDR)
    »óº¸¼º °áÁ¤ºÎÀ§(Ç×üÀÇ)
  • constant region
    ºÒº¯ºÎÀ§(ÝÕܨݻêÈ).
  • constant region
    ºÒº¯ºÎÀ§
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Aortic renal ganglia
    ´ëµ¿¸ÆÄáÆÏ½Å°æÀý
    [¿¾ ¿ë¾î] ´ëµ¿¸Æ½Åµ¿¸Æ½Å°æÀý
  • Left renal vein
    ¿ÞÄáÆÏÁ¤¸Æ
    [¿¾ ¿ë¾î] Á½ÅÁ¤¸Æ
  • Minor renal calices
    ÀÛÀº(ÄáÆÏ)¼úÀÜ
    [¿¾ ¿ë¾î] ¼Ò½Å¹è
  • Collecting renal tubule
    ÁýÇÕ¼¼°ü
    [¿¾ ¿ë¾î] ÁýÇÕ¿ä¼¼°ü
  • Renal branch
    ÄáÆÏ°¡Áö
    [¿¾ ¿ë¾î] ½ÅÁö
  • Renal branches
    ÄáÆÏ°¡Áö
    [¿¾ ¿ë¾î] ½ÅÁö
  • Renal cortex
    ÄáÆÏ°ÑÁú
    [¿¾ ¿ë¾î] ½ÅÇÇÁú
  • Renal cortex
    ÄáÆÏ°ÑÁú
    [¿¾ ¿ë¾î] ÇÇÁú
  • Renal system
    ÄáÆÏ°èÅë
    [¿¾ ¿ë¾î] ½ÅÀå°èÅë
  • Renal fascia
    ÄáÆÏ±Ù¸·
    [¿¾ ¿ë¾î] ½ÅÀå±Ù¸·
  • Renal column
    ÄáÆÏ±âµÕ
    [¿¾ ¿ë¾î] ½ÅÁÖ
  • Renal columns
    ÄáÆÏ±âµÕ
    [¿¾ ¿ë¾î] ½ÅÁÖ
  • Renal pelvis
    ÄáÆÏ±ò¶§±â
    [¿¾ ¿ë¾î] ½Å¿ì
  • Gland of renal pelvis
    ÄáÆÏ±ò¶§±â»ù
    [¿¾ ¿ë¾î] ½Å¿ì¼±
  • Renal crest
    ÄáÆÏ´É¼±
    [¿¾ ¿ë¾î] ½Å´É
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • renal clearance
    ½ÅûÁ¤(ãìôèïä)
  • renal compensation
    ½Åº¸»ó(ãìÜÍßÁ)
  • renal glucosuria
    ½Å(ãì)±Û·çÄÚ½º´¢(Òã)
  • renal hypertension
    ½Å°íÇ÷¾Ð(ãìÍÔúìäâ)
  • renal threshold
    ½Å(ãì)¹®ÅÎ
  • renal tubular acidosis
    ½Å ´¢°ü »êÁõ(ãìÒãη߫ñø)
  • constant region
    ºÒº¯±¸¿ª(ÝÕܨϡæ´)
  • continuous discharge region
    ¿¬¼Ó ¹æÀü±¸¿ª(ææáÙÛ¯ï³Ï¡æ´)
  • core region
    Çٽɱ¸¿ª(ú·ãýÏ¡æ´)
  • C region
    "C ±¸¿ª(Ï¡æ´) (å²) constant region,"
  • crossover region
    ±³Â÷±¸¿ª(Îßó©Ï¡æ´)
  • fingerprint region
    Áö¹®(ò¦Ú£) ºÎÀ§(Ý»êÈ)
  • GC-rich region
    ´Ù(Òý) GC±¸¿ª(Ï¡æ´)
  • hinge region
    µ¹Â¼±Í ±¸¿ª (Ï¡æ´)
  • hv region
    hv ±¸¿ª(Ï¡æ´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • parietotemporopreoccipital region
    µÎÁ¤ÃøµÎÀüÈĵκÎÀ§
  • petrosphenoid region
    ÃßüÁ¢Çü°ñºÎ
  • region
    ºÎ, ºÎÀ§
  • region of interest
    °ü½É±¸¿ª, °ü½É¿µ¿ª
  • ROI [=region of interest]
    °ü½É¿µ¿ª
  • sternocleidomastoid region
    Èä¼âÀ¯µ¹ºÎ
  • central renal echo complex
    ½ÅÁ߽ɿ¡ÄÚº¹ÇÕü
  • hepato renal echo contrast
    °£½ÅÀå¿¡ÄÚ´ëÁ¶
  • renal
    ÄáÆÏÀÇ, ½ÅÀÇ, ½Å¼ºÀÇ, ½ÅÀåÀÇ
  • renal agenesis
    ½Å¹«¹ßÀ°Áõ
  • renal angiography
    ½ÅÇ÷°üÁ¶¿µ¼ú
  • renal arteriogram
    ½Åµ¿¸ÆÁ¶¿µ»ó
  • renal arteriography
    ½Åµ¿¸ÆÁ¶¿µ¼ú
  • renal artery
    ½ÅÀ嵿¸Æ, ½Åµ¿¸Æ, ÄáÆÏµ¿¸Æ
  • renal biopsy
    ½Å»ý°Ë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PAR participating provider; passive avoidance reaction; perennial allergic rhinitis; photosynthetically ...
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
CRT cadaveric renal transplant; cardiac resuscitation team; cathode-ray tube; certified; Certified Recor...
RVRA renal vein rein activity; renal venous renin assay
SRF severe renal failure; skin reactive factor; somatotropin-releasing factor; split renal function; sub...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
3"-UTR 3"-untranslated region
3'NCR 3' non-coding region
3' NTR 3' non-translated region
ICR 3'-internal control region
NCR 3'-noncoding region
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • stress-bearing area : µ¿ÀǾî=stress bearing region.

    stress-bearing region

    ÀÀ·Â ¼ö¿ëºÎ
    ±â´Éµ¿¾È¿¡ Á¶Á÷ ¸é¿¡ ¹ß»ýµÇ´Â Èû, ¾Ð·Â, º¯Çü¿¡ ÀúÇ×ÇÏ´Â Á¶Á÷ ´Ü¸é.
  • abdominal region
    º¹ºÎ
    ¹è ºÎºÐ.
  • buccal region
    ÇùºÎ
  • bulging torus region
    À¶±â ¿µ¿ª
  • caudal region
    ²¿¸®
  • critical region
    ±â°¢ ¿ª
  • cutaneous region
    ÇǺΠºÎÀ§
  • denervated peripheral region
    Å»½Å°æ ¸»ÃÊ ¿µ¿ª
  • framework region
    ±âº» Ʋ
  • infraglottic region
    ¼º¹® ÇϺÎ
  • lateral abdominal region
    Ãøº¹ºÎ
  • lateral hypothalamic region
    ½Ã»ó ÇϺΠ°¡ÂÊ ±¸¿ª
  • lip border region
    ÀÔ¼ú º¯¿¬ ºÎÀ§
  • medial thalamic region
    ³»Ãø ½Ã»ó ¿µ¿ª
  • mental region
    ÅÎ ³¡ ºÎÀ§, ¾Æ·¡ ÅÎ ºÎ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute renal failure <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes.
Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect).
Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement.
(27 Sep 1997)
aminoaciduria, renal Impairment of renal tubular transport of amino acids.
(12 Dec 1998)
back-pressure renal atrophy <radiology> Caliectasis without obstruction, due to repeated episodes of obstruction, gradual loss of renal pyramids
(12 Dec 1998)
base of renal pyramid The outer broad part of a renal pyramid that lies next to the cortex.
Synonym: basis pyramidis renis.
(05 Mar 2000)
branchio-oto-renal syndrome <syndrome> An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation.
(12 Dec 1998)
capsular branches of renal artery <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule.
Synonym: rami capsulares arteriae renalis.
(05 Mar 2000)
captopril renal scan <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis
(12 Dec 1998)
carcinoma, renal cell Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural.
(12 Dec 1998)
renal <anatomy> Pertaining to the kidney, nephric.
(18 Nov 1997)
renal adenocarcinoma <radiology> Hypernephroma, renal cell carcinoma, arises from proximal collecting tubule, 10% bilateral adenocarcinoma types: papillary, alveolar, onchocytoma vascularity, 85% hypervascular (require pre-op embolization), 10% hypovascular (usually papillary type), 5% avascular associated with: tuberous sclerosis, von Hippel-Lindau syndrome see also: staging
(12 Dec 1998)
renal adenocarcinoma: staging <radiology> Typical presentation: Haematuria . . . . . 70% Fever . . . . . . . 16% Pain . . . . . . . . 50% Polycythemia . . . . 3% Palpable mass . . . 20% Anatomic staging (TNM): T1 Small tumour, kidney not enlarged T2 Large tumour, contained within renal capsule T3 Extension into perinephric fat or renal vein T4 Invasion of adjacent organs
(12 Dec 1998)
renal adenocarcinoma: vascularity <radiology> 85% hypervascular (require pre-op embolization), 10% hypovascular (usually the papillary type), 5% avascular also: 10% are bilateral
(12 Dec 1998)
renal agenesis <radiology> Associated with, duplicated vagina and/or uterus (mullerian duct anomaly), seminal vesicle cysts
(12 Dec 1998)
renal agents Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.
(12 Dec 1998)
renal amyloidosis Renal deposits of amyloid, especially in glomerular capillary walls, which may cause albuminuria and the nephrotic syndrome.
Synonym: amyloid nephrosis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • renal
    ½ÅÀåÀÇ
  • renal
    ½ÅÀåÀÇ;½ÅÀåºÎÀÇ
  • renal calculus
    ½Å°á¼®(kidney stone)
  • renal gland
    ºÎ½Å
  • region
    Áö¿ª
  • Centra Region
    ¼¾Æ®·² ¸®Àü(¿µ±¹ ½ºÄÚÆ²·£µå ÁߺÎÀÇ ÇàÁ¤±¸)
  • F region
    (Àü¸®ÃþÀÇ) F Ãþ
  • critical region
    ±â°¢¿ª;À§Ç迪(°¡¼³ °ËÁ¤¿¡ À־ÀÇ)
  • flight information region
    ºñÇà Á¤º¸ ±¸¿ª
  • isothermal region
    STRATOSPHERE
  • photic region(zone)
    Åõ±¤´ë
  • proportional region
    ºñ·Ê °è¼ö¿ª
  • region
    (¸íÈ®ÇÑ ÇѰ谡 ¾ø´Â ±¤´ëÇÑ)Áö¹æ;Áö¿ª;Áö´ë;(¼öµµ¿¡¼­ ¶³¾îÁø)Áö¹æ;½Ã°ñ;(õÁö¸¦ »óÇÏ·Î ±¸ºÐÇÑ)ºÎÁØ;¿ª;°æ;°è(¼¼°è ¶Ç´Â ¿ìÁÖÀÇ);Ãþ(´ë±â ¶Ç´Â ¹Ù´ÙÀÇ);(¿¹¼ú.Çй®µîÀÇ)¹üÀ§;¿µ¿ª;ºÐ¾ß;(¿¹¼ú.Çй® µîÀÇ)¹üÀ§;¿µ¿ª;ºÐ¾ß;(½ÅüÀÇ)ºÎÀ§;±¹ºÎ;ÇàÁ¤±¸;°ü±¸;±¸;(1975³â ½ºÄÚÆ²·£
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á